ORG Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History

ORG Wealth Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$165	Buy	+2	New	+$177	﹤0.01%	2383

Other funds holding LMAT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return

ORG Wealth Partners's LMAT Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in LeMaitre Vascular (LMAT) in Q3 2026: 2 shares worth $165. The stake represents ﹤0.01% of the portfolio and ranks #2383 among its holdings.

238 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

ORG Wealth Partners held 2 shares of LeMaitre Vascular worth $165 as of Q3 2026.
LeMaitre Vascular was a new ORG Wealth Partners position in Q3 2026.
LeMaitre Vascular made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2383 holding.
238 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.